Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lisa Lubsch"'
Autor:
Kelly L. Matson, David S. Hoff, Lisa Lubsch, Robert C Hellinga, Rachel Meyers, Jennifer Thackray, Christopher McPherson
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 25:175-191
OBJECTIVES The safe use of medications in pediatric patients requires practitioners to consider the unique pharmacokinetics and pharmacodynamics of drugs prescribed in this age group. In an effort to create a standard of care for the safe use of medi
Autor:
Jennifer Hewlett, Laura Shanley, Elizabeth B. Autry, Hunter Ragan, Lisa Lubsch, Lauren Kormelink, Taryn Bomersback, Julie Safirstein
INTRODUCTION Cystic fibrosis (CF) related liver disease (CFLD) manifests as a wide spectrum of hepatobiliary disease and can progress to need liver transplantation. Elexacaftor/tezacaftor/ivacaftor (elx/tez/iva) is a cystic fibrosis transmembrane con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::737d7bee3323b66879fcb2911b12f970
https://doi.org/10.22541/au.162429396.62065467/v1
https://doi.org/10.22541/au.162429396.62065467/v1
Autor:
Brett M. Hemmann, Paula Buchanan, Howard L. Williams, Justin B. Josephsen, Lisa Lubsch, Connie D. Anderson, Noah H. Hillman, Brianna M. Hemmann
Publikováno v:
Journal of perinatology : official journal of the California Perinatal Association. 42(1)
To determine if extremely preterm (EPT) neonates receiving dexamethasone for the prevention of BPD have a higher incidence of presumed adrenal insufficiency (PAI). Retrospective cohort study of neonates
Publikováno v:
Pediatric Pulmonology. 56:4053-4054
Autor:
David C. Young, Chris Stockmann, Jahidur Rashid, Kwabena Krow Ampofo, Lisa Lubsch, Adam Frymoyer, Jeffery T. Zobell, Catherine M.T. Sherwin, Jared K. Olson, Xiaoxi Liu, Yuhuan Wang, Adam L. Hersh
Publikováno v:
The Journal of Clinical Pharmacology. 59:198-205
The prevalence of pulmonary methicillin-resistant Staphylococcus aureus infections in patients with cystic fibrosis (CF) has increased over the last 2 decades. Two concentrations-a postdistributive and a trough-are currently used to estimate the area
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 22:9-14
OBJECTIVES Tracheitis is an infection of the lower respiratory tract and is defined by the US Centers for Disease Control and Prevention (CDC) based on signs and symptoms with no radiographic evidence of pneumonia. One method of treatment involves th
Autor:
Lori Chen, Lisa Lubsch, Alison G. Grisso, Cameron J. McKinzie, Catherine E. O'Brien, Brittany A. Wright, Kim Ehlert, E. Claire Elson, Alice C. Pan, Alaina Linafelter
Publikováno v:
Pediatric Pulmonology. 54
Management of infections in patients with cystic fibrosis (CF) presents challenges for healthcare providers, including the eradication of initial acquisition, treatment of acute exacerbations, and chronic infection with suppressive therapy. Inhaled a
Autor:
Peter Johnson, Joseph M. LaRochelle, Mary A. Worthington, Katherine P. Smith, Chad A. Knoderer, Justin W. Cole, Timothy J. Todd, Christina L. Cox, Kristin C. Klein, Rachel Meyers, William A. Prescott, Lisa Lubsch
Publikováno v:
Am J Pharm Educ
Providing health care for children is a unique specialty, and pediatric patients represent approximately 25% of the population. Education of pharmacy students on patients across the lifespan is required by current Accreditation Council for Pharmacy E
Autor:
Denis Hadjiliadis, Margaret Rosenfeld, Felix Ratjen, Leslie Hazle, Bruce C. Marshall, Margaret F. Guill, Thomas Lahiri, Kathy Sabadosa, Karen A. Robinson, Jane Matsui, Christopher M. Oermann, Cynthia Brady, Gary A. Mueller, Richard Simon, Jeffrey B. Hoag, Peter J. Mogayzel, Edward T. Naureckas, Lisa Lubsch
Publikováno v:
Annals of the American Thoracic Society. 11:1640-1650
The Cystic Fibrosis (CF) Foundation developed clinical care guidelines for the prevention of Pseudomonas aeruginosa infection, the treatment of initial P. aeruginosa infection, and the use of bronchoscopy to obtain routine airway cultures in individu
Autor:
Blakeslee E. Noyes, Catherine M.T. Sherwin, David C. Young, Jeffery T. Zobell, Krow Ampofo, Jared K. Olson, Chris Stockmann, Michael G. Spigarelli, Lisa Lubsch
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 33:1288-1296
Vancomycin is the drug-of-choice for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in children with cystic fibrosis. However, no studies have characterized the pharmacokinetic profile of vancomycin among pediatric cys